$4.39+0.07 (+1.50%)
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA Technologies, Inc. in the Healthcare sector is trading at $4.39. The stock is currently near its 52-week low of $4.10, remaining 24.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus...
In the last week, the market has been flat, but over the past 12 months, it has risen by 27%, with earnings forecasted to grow by 17% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points when backed by strong balance sheets and solid fundamentals. In this article, we explore several compelling penny stocks that stand out as hidden gems in today's market landscape.
SIGA Technologies, Inc. has released its first-quarter 2026 results, reporting revenue of US$6.24 million versus US$7.04 million a year earlier and a net loss of US$3.45 million compared with US$0.41 million previously. The widening loss per share from continuing operations, rising to US$0.05 from US$0.01, suggests higher pressure on profitability relative to last year. Next, we examine how SIGA’s weaker first-quarter revenue and sharply higher net loss shape the company’s investment...
The market for SIGA Technologies, Inc.'s ( NASDAQ:SIGA ) shares didn't move much after it posted weak earnings...
Siga Technologies (NASDAQ:SIGA) reported a first-quarter loss as product deliveries remained minimal, but management said it expects a pickup in the second quarter tied to an international order and additional deliveries to the U.S. Strategic National Stockpile. Chief Executive Officer Diem Nguyen
Over the last 7 days, the United States market has risen 3.2%, with a notable climb of 31% over the past year and earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks that combine solid financials with growth potential becomes crucial for investors. Penny stocks, although an outdated term, remain relevant as they often represent smaller or newer companies that can offer unique opportunities for significant returns when backed by strong...